AT268595T
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
37 members in 12 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 11261798 | United States of America | P | |
| 11261798 | United States of America | P | |
| 9902095 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 9902095 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| 112617P | – | – | – |
| 9902095 | – | – | – |
| US19980112617P | – | – | – |
| WO1999IB02095 | – | – | – |
Members37
| Document | Office | Kind | |
|---|---|---|---|
| CA2355854A1 | Canada | A1 | |
| WO0035426A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2122700A | Australia | A | |
| WO0035426A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1143937A2 | European Patent Office (EPO) | A2 | |
| US6419960B1 | United States of America | B1 | |
| JP2002532410A | Japan | A | |
| US2003054033A1 | United States of America | A1 | |
| EP1143937B1 | European Patent Office (EPO) | B1 | |
| AT268595TThis record | Austria | T | |
| ATE268595T1 | Austria | T1 | |
| DE69917937D1 | Germany | D1 | |
| DK1143937T3 | Denmark | T3 | |
| PT1143937E | Portugal | E | |
| SI1143937T1 | Slovenia | T1 | |
| ES2224740T3 | Spain | T3 | |
| DE69917937T2 | Germany | T2 | |
| US7247318B2 | United States of America | B2 | |
| US2007264325A1 | United States of America | A1 | |
| CA2355854C | Canada | C | |
| US7438930B2 | United States of America | B2 | |
| JP4172917B2 | Japan | B2 | |
| US2009123554A1 | United States of America | A1 | |
| US8580310B2 | United States of America | B2 | |
| US2014099361A1 | United States of America | A1 | |
| US9066869B2 | United States of America | B2 | |
| US2015313850A1 | United States of America | A1 | |
| US2017071926A1 | United States of America | A1 | |
| US2017079921A1 | United States of America | A1 | |
| US2017135999A1 | United States of America | A1 | |
| US9801823B2 | United States of America | B2 | |
| US2018008544A1 | United States of America | A1 | |
| US2018042854A1 | United States of America | A1 | |
| US9949931B2 | United States of America | B2 | |
| US10022330B2 | United States of America | B2 | |
| US10039719B2 | United States of America | B2 | |
| US10463624B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Publication, DOCDB
- 268595
- Publication, EPODOC
- AT268595T
- Application
- 99965601
- Application, DOCDB
- 99965601
- Application, EPODOC
- AT19990965601T
Titles2
- German
- FORMULIERUNGEN MIT GESTEUERTER FREISETZUNG, DIE EINEN SCHNELLEN EINTRITT UND EINEN SCHNELLEN ABFALL DER WIRKSAMEN ARZNEISTOFFPLASMAKONZENTRATIONEN HABEN
- English
- CONTROLLED RELEASE FORMULATIONS THAT HAVE A FAST ADMISSION AND FAST WASTE OF EFFECTIVE DRUG PLASMA CONCENTRATIONS
Classification
- CPC, 16
- A61K9/2081
- A61K9/209
- A61K9/167
- A61K9/5078
- A61K9/5084
- A61K31/4458
- A61P25/00
- A61P25/14
- A61K9/0053
- A61K9/5089
- A61K9/2086
- A61K9/2846
- A61K9/2893
- A61K9/5026
- A61K9/5047
- A61K9/5073
- IPC, 5
- A61K9 22
- A61K9 26
- A61K9 50
- A61K9 54
- A61K31 4458